Woodline Partners LP

74 employees

Woodline Partners is a private equity firm that focuses on the healthcare and technology sectors.

Investor insights

Sectors invested in

Biotechnology27

Health Care17

Therapeutics13

Pharmaceutical11

Medical9

Biopharma6

Life Science5

Artificial Intelligence3

Information Technology2

mHealth2

biotechnology2

Wellness2

Oncology2

Machine Learning2

Bloggers1

Pharmaceuticals1

Biopharmaceuticals1

Therapeutics for the treatment of rare diseases1

small molecules1

pharmaceuticals1

Funding rounds participated in

$135M sweet spot round size

Most of their 33 investments are in rounds between $100M and $186M

Investor type

Private Equity Firm

Basic info

Industry

financial services

Sectors

Financial Services

Health Care

Software

Date founded

2018

Investments made

Soleno Therapeutics, Inc. raised $129M on September 28, 2023

Investors: Perceptive Advisors, Commodore Capital, LP, Adage Capital Management and Woodline Partners LP

Olema Oncology raised $130M on September 5, 2023

Investors: Logos Global Management, LP, Vivo Capital, Lightspeed Venture Partners and Woodline Partners LP

Septerna raised $150M on July 11, 2023

Investors: Goldman Sachs Asset Management, The Invus Group, Third Rock Ventures, RA Capital Management, L.P., Soleus Capital Management, L.P., Samsara BioCapital, Logos Global Management, LP, Vertex Ventures HC and Woodline Partners LP

Immunome, Inc. raised $125M on June 29, 2023

Investors: Avidity Partners, Redmile Group, Enavate Sciences and Woodline Partners LP

Lyra Therapeutics raised $50M on May 26, 2023

Investors: Armistice Capital LLC, Samsara BioCapital, Surveyor Capital, Perceptive Advisors and Woodline Partners LP

Orchard Therapeutics raised $34M on March 6, 2023

Investors: RA Capital Management, L.P. and Woodline Partners LP

Fusion Pharmaceuticals raised $60M on February 13, 2023

Investors: The Invus Group, Avidity Partners and Woodline Partners LP

Odyssey Therapeutics raised $168M on October 13, 2022

Investors: Walleye Capital, SVB Securities, Logos Global Management, LP, General Catalyst, OrbiMed Advisors, GreatPoint Ventures, S.R. One Ltd, T. Rowe Price and Woodline Partners LP

Ventyx Biosciences raised $177M on September 19, 2022

Investors: Great Point Partners, Walleye Capital, Logos Global Management, LP, CaaS Capital Management, Vivo Capital, Redmile Group, Driehaus Capital Management LLC and Woodline Partners LP

Maze Therapeutics raised $190M on January 10, 2022

Investors: NS Investment, General Catalyst, Casdin Capital, LLC, Foresite Capital, City Hill Ventures, Driehaus Capital Management LLC and Woodline Partners LP